This presentation will focus on key safety considerations for pain, depression, and anxiety medication management in the primary care setting. The pain management section will provide information about buprenorphine and cannabis and review basic safety guidelines. The depression segment will focus on diagnostic accuracy and suicide risk and explain the use of recommended atypical antipsychotics. The anxiety section will focus on the detriments of long-term treatment with benzodiazepines and recommend safer alternatives. Learning Objectives: 1) New harm reduction ideas for pain management 2) Identify potential pitfalls of depression treatment 3) Review salient safety concerns about anxiety medications
- Provider:Missouri Association of Osteopathic Physicians and Surgeons (MAOPS)
- Activity Link: https://maops.ce21.com/search?search=Safe%20Prescribing%20for%20Pain%2C%20Depression%20%26%20Anxiety
- Start Date: 2023-09-28 05:00:00
- End Date: 2023-09-28 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest